Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor.
Sign Up to like & getrecommendations! Published in 2020 at "European urology oncology"
DOI: 10.1016/j.euo.2020.08.007
Abstract: BACKGROUND There is controversy regarding the management of patients with normal markers and residual masses (≤1 cm) after chemotherapy for nonseminomatous germ cell tumors (NSGCTs). OBJECTIVE To determine long-term outcomes of a surveillance strategy in such… read more here.
Keywords: chemotherapy; chemotherapy metastatic; following chemotherapy; germ cell ... See more keywords
Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial.
Sign Up to like & getrecommendations! Published in 2020 at "European urology"
DOI: 10.1016/j.eururo.2020.04.061
Abstract: BACKGROUND In the PREVAIL study, enzalutamide significantly improved clinical outcomes versus placebo in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC). OBJECTIVE To evaluate long-term benefits and risks of enzalutamide in the final prespecified PREVAIL… read more here.
Keywords: chemotherapy metastatic; metastatic castration; prostate cancer; survival ... See more keywords
Nivolumab with or without chemotherapy for metastatic gastroesophageal cancers and future perspectives
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2139241
Abstract: ABSTRACT Introduction Gastroesophageal cancers (GEC) are frequently found at the advanced stage. GEC treatment advancements have been limited and prognosis, therefore, remains poor. Through numerous clinical trials, the addition of immune checkpoint inhibitors, including nivolumab,… read more here.
Keywords: nivolumab without; gastroesophageal; chemotherapy metastatic; gastroesophageal cancers ... See more keywords
Alternatives to Perpetual Chemotherapy for Metastatic Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-21-0612
Abstract: With the advent of multiagent chemotherapy for metastatic pancreatic cancer, subgroups of patients whose disease responds durably to treatment are emerging. Although this is wonderful progress in the face of a deadly illness, cumulative toxicities… read more here.
Keywords: metastatic pancreatic; cancer; chemotherapy metastatic; perpetual chemotherapy ... See more keywords
Understanding the goals of chemotherapy for metastatic cancer: A survey of patients receiving palliative treatment in the Philippines.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.31_suppl.28
Abstract: 28Background: Chemotherapy for metastatic cancer is, for most cases, primarily given with palliative intent. An unrealistic expectation of cure with chemotherapy can influence a patient’s decision to receive treatment with significant physical, financial and psychological… read more here.
Keywords: chemotherapy metastatic; treatment; patients receiving; receiving palliative ... See more keywords
Single-institute outcomes of palliative chemotherapy in metastatic head and neck squamous cell carcinoma (HNSCC).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e18513
Abstract: e18513Background: Distantly metastatic HNSCC carries a poor prognosis with limited palliative systemic treatment options and a paucity of literature examining factors impacting outcomes of such the... read more here.
Keywords: outcomes palliative; institute outcomes; chemotherapy metastatic; single institute ... See more keywords
Impact of omitting fluorouracil from FOLFIRI plus bevacizumab as second-line chemotherapy for metastatic colorectal cancer patients.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.3_suppl.76
Abstract: 76Background: FOLFIRI + bevacizumab (FOLFIRI + BEV) is a standard second-line chemotherapy (Cx) for metastatic colorectal cancer (mCRC) patients (pts) who are refractory or intolerant to fluoropyri... read more here.
Keywords: chemotherapy metastatic; second line; metastatic colorectal; line chemotherapy ... See more keywords
Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2021 at "AntiCancer Research"
DOI: 10.21873/anticanres.14977
Abstract: Background/Aim: FOLFOX (5-Fluorouracile and oxaliplatin) exhibits promising activity in advanced well-differentiated neuroendocrine tumors (NETs). This retrospective study aimed to analyze the outcome of metastatic enteropancreatic NETs patients treated with FOLFOX. Patients and Methods: We retrospectively… read more here.
Keywords: folfox chemotherapy; chemotherapy metastatic; efficacy folfox; neuroendocrine tumors ... See more keywords